Join Now

Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis

SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug Administration (FDA) for Embosphere® Microspheres for the Genicular Artery Embolization (GAE) indication. GAE is a procedure intended to reduce pain and disability caused by knee osteoarthritis by […]

Posted in BioUtah News | Tagged | Leave a comment

Merit Medical rises on Street-beating Q4, sets 2022 guidance

Merit Medical shares were up today on fourth-quarter results that topped the consensus forecast.

Posted in BioUtah News | Tagged | Leave a comment